1. Home
  2. RLI vs HALO Comparison

RLI vs HALO Comparison

Compare RLI & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RLI Corp. (DE)

RLI

RLI Corp. (DE)

HOLD

Current Price

$65.43

Market Cap

5.9B

Sector

Finance

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$64.63

Market Cap

7.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLI
HALO
Founded
1965
1998
Country
United States
United States
Employees
1147
N/A
Industry
Property-Casualty Insurers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.9B
7.4B
IPO Year
1985
N/A

Fundamental Metrics

Financial Performance
Metric
RLI
HALO
Price
$65.43
$64.63
Analyst Decision
Hold
Buy
Analyst Count
6
12
Target Price
$72.80
$73.33
AVG Volume (30 Days)
727.4K
2.5M
Earning Date
01-21-2026
11-03-2025
Dividend Yield
4.10%
N/A
EPS Growth
N/A
56.68
EPS
3.82
4.74
Revenue
$1,855,871,000.00
$1,242,852,000.00
Revenue This Year
N/A
$34.83
Revenue Next Year
$4.83
$24.84
P/E Ratio
$16.84
$13.14
Revenue Growth
5.16
31.19
52 Week Low
$57.75
$46.26
52 Week High
$86.05
$79.50

Technical Indicators

Market Signals
Indicator
RLI
HALO
Relative Strength Index (RSI) 63.69 44.64
Support Level $60.91 $61.23
Resistance Level $63.35 $63.26
Average True Range (ATR) 1.12 2.25
MACD 0.26 -0.34
Stochastic Oscillator 92.35 26.22

Price Performance

Historical Comparison
RLI
HALO

About RLI RLI Corp. (DE)

RLI Corp underwrites property and casualty insurance through its subsidiaries. The company offers insurance coverage in the specialty admitted market, where the products are designed for special risks. It also offers products in the excess and surplus markets, which provides an alternative for customers with risks or loss exposures that generally cannot be written in the standard admitted market. RLI distributes property and casualty insurance through its wholly-owned branch offices that market to wholesale and retail producers. The company's insurance operation segments include Casualty, Property, and Surety and it derives a majority of its revenue from the Casualty segment.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: